INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 30 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,000 | -20.0% | 20,072 | +100.0% | 0.00% | – |
| Q3 2019 | $5,000 | -28.6% | 10,036 | 0.0% | 0.00% | – |
| Q2 2019 | $7,000 | -53.3% | 10,036 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | -50.0% | 10,036 | -50.0% | 0.00% | – |
| Q4 2018 | $30,000 | +50.0% | 20,072 | +100.0% | 0.00% | – |
| Q3 2018 | $20,000 | +17.6% | 10,036 | 0.0% | 0.00% | – |
| Q2 2018 | $17,000 | – | 10,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|